Agency Information Collection Activities; Proposed Collection; Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications; Correction

---
identifier: "/us/fr/2012-4168"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Agency Information Collection Activities; Proposed Collection; Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2012-4168"
section_name: "Agency Information Collection Activities; Proposed Collection; Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications; Correction"
positive_law: false
currency: "2012-02-23"
last_updated: "2012-02-23"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2012-4168"
document_type: "notice"
publication_date: "2012-02-23"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "77 FR 10752"
fr_volume: 77
docket_ids:
  - "Docket No. FDA-2012-N-0129"
fr_action: "Notice; correction."
---


#  Agency Information Collection Activities; Proposed Collection; Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

The Food and Drug Administration (FDA) is correcting a notice that appeared in the *Federal Register* of February 15, 2012 (77 FR 8880). The document announced an opportunity for public comment on the proposed collection of certain information by the Agency. The document was published with an incorrect docket number. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Joyce Strong, Office of Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 3208,  Silver Spring, MD 20993-0002, 301-796-9148.

**SUPPLEMENTARY INFORMATION:**

In FR Doc. 2012-3548, appearing on page 8880, in the *Federal Register* of Wednesday, February 15, 2012, the following correction is made:

On page 8880, in the second column, in the Docket No. heading, “[Docket No. FDA-2012-N-1029]” is corrected to read “[Docket No. FDA-2012-N-0129]”.

Dated: February 16, 2012.

Leslie Kux,

Acting Assistant Commissioner for Policy.